Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Biochemical and ultrastructural changes in the adrenal glands of rats were observed after long-term phenobarbital treatment. At the fine structural level, the parenchymal cells of the phenobarbital-treated rats resembled cortical cells that had been stimulated by
adrenocorticotropin
. A significant finding was the presence of very large hollow mitochondria characterized by loss of vesicles and cristae with retention of the double outer membrane. Arylesterase (
EC 3.1.1.2
) activity, the marker used for rough endoplasmic reticulum, was significantly diminished. Since rough endoplasmic reticulum is present primarily in the adrenal medulla and not the cortex, the relative decrease in
arylesterase
activity is consistent with the morphologic adrenal cortical hyperplasia. Trypsin-like (EC 3.4.4.4) enzyme activity was increased. The plasma corticosterone response to
adrenocorticotropin
injection was not significantly different in treated and control rats. The similarity of the observed mitochondrial changes to the reported mitochondrial cavitation in the adrenal glands of rats treated with aminoglutethimide is discussed.
...
PMID:Biochemical, morphologic and physiologic changes in the adrenal glands of rats chronically treated with phenobarbital. 68 69